We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Wearable Rapid Gas Analyzer Could Detect Illness Immediately

By LabMedica International staff writers
Posted on 08 Aug 2022

Advancements in micro-gas chromatography in the past 20 years have demonstrated great potential for the development of powerful portable gas analysis devices. More...

But it remains a challenge to achieve efficient separation and rapid detection for effective gas analysis in a highly integrated and cost-effective platform, as well as in a mobile device. Now, researchers are creating a portable, wearable device for rapid gas analysis that could detect illness immediately.

The device being created by electrical engineering researchers at The University of Texas at Arlington (Arlington, TX, USA) will play an important role in health care, among other sectors. The project will create technology to transform a powerful gas analysis instrument traditionally used in research labs into portable and wearable devices that are easily accepted and accessible by the public. The project has received a USD 550,000 National Science Foundation (NSF) grant from the Partnerships for Innovation–Research Partnerships program, which aims to take devices developed in the laboratory to the marketplace more quickly.

The vast applications could propel the device to the marketplace more quickly. In health care, the device could analyze a person’s breath samples to find chemical markers that are specifically linked to infections, cancers and other health conditions. In turn, that could lead to a convenient and rapid health screening and monitoring tool to be used at home.

“The key to the project is system-level integration, including creating new micro-gas chromatography architecture and using photonic integrated circuits to achieve rapid and comprehensive volatile organic compounds gas analysis,” said Yuze “Alice” Sun, an associate professor in the Department of Electrical Engineering, who is the principal investigator on the project.

“Not only does the project have the potential of improving our lives, but it could take up so much less space than current chromatography analysis machines,” said Diane Huffaker, chair and professor of electrical engineering. “This could save an enormous amount of testing time, too.”

Related Links:
The University of Texas at Arlington 


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
βeta-Hydroxybutyrate Reagent
β-Hydroxybutyrate LiquiColor®
Fully Automated Urinalysis System
DxU 1800 Fully Automated Urinalysis System
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The test combines RNA signals from the tumor-immune microenvironment to predict treatment response, rather than relying on a single marker such as PD-L1 expression.(Image Credit: Adobe Stock)

RNA-Based Test Predicts Immunotherapy Response in Non-Small Cell Lung Cancer

Non-small cell lung cancer (NSCLC) represents the largest U.S. patient population eligible for immune checkpoint inhibitor therapy. Treatment selection often relies on PD-L1 expression, but a single protein... Read more

Immunology

view channel
Image Credit: Adobe Stock

Immune Profiling Identifies Early Maternal Autoantibodies Linked to Preterm Birth Risk

A typical pregnancy lasts about 40 weeks, but labor begins prematurely in roughly one in 10 pregnancies. Preterm birth is the leading cause of newborn death worldwide, yet its underlying causes and which... Read more

Industry

view channel
Image Credit: iStock

Global TB Summit Connects Diagnostic Testing With Prevention and Clinical Care

Tuberculosis remains a major global infectious disease challenge despite declining deaths. In 2024, an estimated 10.7 million people worldwide developed the disease and nearly 1.2 million died from it.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.